Cellular STAT3 functions via PCBP2 to restrain epstein-barr virus lytic activation in B lymphocytes

Journal of Virology

Volumn 89, Issue 9, 2015, Pages 5002-5011

  Koganti, Siva ^a   Clark, Carissa ^a   Zhi, Jizu ^a   Li, Xiaofan ^a   Chen, Emily I ^b,c   Chakrabortty, Sharmistha ^a   Hill, Erik R ^a,d   Bhaduri McIntosh, Sumita ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Department of Medicine   (United States)

^d CAMPBELL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLY(C)BINDING PROTEIN 2; RNA BINDING PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; PCBP2 PROTEIN, HUMAN; PROTEOME; STAT3 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HNRPDL GENE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PCBP2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RBM17 GENE; RNA PROCESSING; SNRPD1 GENE; STAT3 GENE; TRANSCRIPTION REGULATION; UTP14A GENE; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS REPLICATION; CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROARRAY ANALYSIS; PROTEOME; RNA-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR; VIRUS ACTIVATION;

EID: 84928524205     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00121-15     Document Type: Article

References (41)

1. Bhaduri-McIntosh S. 2005. Human herpesvirus-8: clinical features of an emerging viral pathogen. Pediatr Infect Dis J 24:81-82. http://dx.doi.org/10.1097/01.inf.0000151367.14455.9c.
2. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481-492. http://dx.doi.org/10.1056/NEJM200008173430707.
3. Thorley-Lawson DA, Gross A. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328-1337. http://dx.doi.org/10.1056/NEJMra032015.
4. Hippocrate A, Oussaief L, Joab I. 2011. Possible role of EBV in breast cancer and other unusually EBV-associated cancers. Cancer Lett 305:144-149. http://dx.doi.org/10.1016/j.canlet.2010.11.007.
5. Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. 2012. Epstein-Barr virus (EBV)-associated gastric carcinoma. Viruses 4:3420-3439. http://dx.doi.org/10.3390/v4123420.
6. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS, HCMV and Gliomas Symposium. 2012. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246-255. http://dx.doi.org/10.1093/neuonc/nor227.
7. Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. 2007. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood 109:2571-2578. http://dx.doi.org/10.1182/blood-2006-01-024703.
8. Daigle D, Megyola C, El-Guindy A, Gradoville L, Tuck D, Miller G, Bhaduri-McIntosh S. 2010. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors. J Virol 84:993-1004. http://dx.doi.org/10.1128/JVI.01745-09.
9. Hill ER, Koganti S, Zhi J, Megyola C, Freeman AF, Palendira U, Tangye SG, Farrell PJ, Bhaduri-McIntosh S. 2013. Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes. J Virol 87:11438-11446. http://dx.doi.org/10.1128/JVI.01762-13.
10. Bhaduri-McIntosh S, Miller G. 2006. Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBVseropositive individuals. J Virol Methods 137:103-114. http://dx.doi.org/10.1016/j.jviromet.2006.06.006.
11. Heston L, Rabson M, Brown N, Miller G. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295:160-163. http://dx.doi.org/10.1038/295160a0.
12. Koganti S, Hui-Yuen J, McAllister S, Gardner B, Grasser F, Palendira U, Tangye SG, Freeman AF, Bhaduri-McIntosh S. 2014. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation. Proc Natl Acad Sci USA 111:4946-4951. http://dx.doi.org/10.1073/pnas.1400683111.
13. Chen EI, Hewel J, Felding-Habermann B, Yates JR, III. 2006. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol Cell Proteomics 5:53-56. http://dx.doi.org/10.1074/mcp. T500013-MCP200.
14. Yates JR, III, Eng JK, McCormack AL, Schieltz D. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67:1426-1436. http://dx.doi.org/10.1021/ac00104a020.
15. Tabb DL, McDonald WH, Yates JR, III. 2002. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res 1:21-26. http://dx.doi.org/10.1021/pr015504q.
16. Park SK, Yates JR, III. 2010. Census for proteome quantification. Curr Protoc Bioinformatics Chapter 13:Unit 13.12.1-11. http://dx.doi.org/10.1002/0471250953.bi1312s29.
17. Li C, Wong WH. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36. http://dx.doi.org/10.1073/pnas.98.1.31.
18. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211.
19. ENCODE Project Consortium. 2011. A user's guide to the encyclopedia ofDNAelements (ENCODE). PLoS Biol 9:e1001046. http://dx.doi.org/10.1371/journal.pbio.1001046.
20. Makeyev AV, Liebhaber SA. 2002. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8:265-278. http://dx.doi.org/10.1017/S1355838202024627.
21. Dinh PX, Beura LK, Panda D, Das A, Pattnaik AK. 2011. Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression. J Virol 85:9459-9471. http://dx.doi.org/10.1128/JVI.05179-11.
22. Ghosh D, Srivastava GP, Xu D, Schulz LC, Roberts RM. 2008. A link between SIN1 (MAPKAP1) and poly(rC) binding protein 2 (PCBP2) in counteracting environmental stress. Proc Natl Acad Sci USA 105:11673-11678. http://dx.doi.org/10.1073/pnas.0803182105.
23. Vogt DA, Andino R. 2010. An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog 6:e1000936. http://dx.doi.org/10.1371/journal.ppat.1000936.
24. Xin Z, Han W, Zhao Z, Xia Q, Yin B, Yuan J, Peng X. 2011. PCBP2 enhances the antiviral activity of IFN-alpha againstHCVby stabilizing the mRNA of STAT1 and STAT2. PLoS One 6:e25419. http://dx.doi.org/10.1371/journal.pone.0025419.
25. Darnell JE, Jr. 2002. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749. http://dx.doi.org/10.1038/nrc906.
26. Nepomuceno RR, Snow AL, Beatty RP, Krams SM, Martinez OM. 2002. Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder. Transplantation 74:396-402. http://dx.doi.org/10.1097/00007890-200208150-00017.
27. Yu H, Jove R. 2004. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4:97-105. http://dx.doi.org/10.1038/nrc1275.
28. Hu L, Wang J, Liu Y, Zhang Y, Zhang L, Kong R, Zheng Z, Du X, Ke Y. 2011. A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation. J Biol Chem 286:3119-3128. http://dx.doi.org/10.1074/jbc. M110.157842.
29. Kawamura H, Tomozoe Y, Akagi T, Kamei D, Ochiai M, Yamada M. 2002. Identification of the nucleocytoplasmic shuttling sequence of heterogeneous nuclear ribonucleoprotein D-like protein JKTBP and its interaction with mRNA. J Biol Chem 277:2732-2739. http://dx.doi.org/10.1074/jbc. M108477200.
30. Omnus DJ, Mehrtens S, Ritter B, Resch K, Yamada M, Frank R, Nourbakhsh M, Reboll MR. 2011. JKTBP1 is involved in stabilization and IRES-dependent translation of NRF mRNAs by binding to 5' and 3' untranslated regions. J Mol Biol 407:492-504. http://dx.doi.org/10.1016/j.jmb.2011.01.050.
31. Zeiner GM, Foldynova S, Sturm NR, Lukes J, Campbell DA. 2004. SmD1 is required for spliced leader RNA biogenesis. Eukaryot Cell 3:241-244. http://dx.doi.org/10.1128/EC.3.1.241-244.2004.
32. Ding Y, Li XR, Yang KY, Huang LH, Hu G, Gao K. 2013. Proteomics analysis of gastric epithelial AGS cells infected with Epstein-Barr virus. Asian Pac J Cancer Prev 14:367-372. http://dx.doi.org/10.7314/APJCP.2013.14.1.367.
33. Malik-Soni N, Frappier L. 2012. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J Virol 86:6999-7002. http://dx.doi.org/10.1128/JVI.00194-12.
34. Ivaldi C, Martin BR, Kieffer-Jaquinod S, Chapel A, Levade T, Garin J, Journet A. 2012. Proteomic analysis of S-acylated proteins in human B cells reveals palmitoylation of the immune regulators CD20 and CD23. PLoS One 7:e37187. http://dx.doi.org/10.1371/journal.pone.0037187.
35. Lippe R. 2012. Deciphering novel host-herpesvirus interactions by virion proteomics. Front Microbiol 3:181. http://dx.doi.org/10.3389/fmicb.2012.00181.
36. Meckes DG, Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N. 2013. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci USA 110:E2925-E2933. http://dx.doi.org/10.1073/pnas.1303906110.
37. Lundberg E, Fagerberg L, Klevebring D, Matic I, Geiger T, Cox J, Algenas C, Lundeberg J, Mann M, Uhlen M. 2010. Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 6:450. http://dx.doi.org/10.1038/msb.2010.106.
38. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. 2011. Global quantification of mammalian gene expression control. Nature 473:337-342. http://dx.doi.org/10.1038/nature10098.
39. Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE. 2004. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 3:960-969. http://dx.doi.org/10.1074/mcp. M400055-MCP200.
40. Vogel C, de Sousa Abreu R, Ko D, Le SY, Shapiro BA, Burns SC, Sandhu D, Boutz DR, Marcotte EM, Penalva LO. 2010. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol 6:400. http://dx.doi.org/10.1038/msb.2010.59.
41. Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, Ganem D, Middeldorp J, Wiertz EJ, Ressing ME. 2007. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci USA 104:3366-3371. http://dx.doi.org/10.1073/pnas.0611128104.